KetamineOne Capital Limited announced that it is entering into a collaborative partnership with Cognetivity Neurosciences Ltd. to study and develop assessments for depression and post-traumatic stress disorder (PTSD).
[KetamineOne Capital Limited]
Sorry, but the selected Zotpress account can't be found.